Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Total Non-Current Liabilities

    Back to Balance Sheet
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

VENUS REMEDIES Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹18 Cr₹60 Cr₹58 Cr₹46 Cr₹58 Cr

What is the latest Total Non-Current Liabilities ratio of VENUS REMEDIES ?

The latest Total Non-Current Liabilities ratio of VENUS REMEDIES is ₹18 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹18 Cr
Mar2024₹60 Cr
Mar2023₹58 Cr
Mar2022₹46 Cr
Mar2021₹58 Cr

How is Total Non-Current Liabilities of VENUS REMEDIES Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹18 Cr
-69.12
Mar2024 ₹60 Cr
2.89
Mar2023 ₹58 Cr
26.60
Mar2022 ₹46 Cr
-20.94
Mar2021 ₹58 Cr -

Compare Total Non-Current Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹1,202.5 Cr 1.8% 33.5% 208.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

1.8%

33.5%

208.9%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses